Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, Guangdong Province, China.
College of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Int J Med Sci. 2021 Jan 1;18(2):335-346. doi: 10.7150/ijms.50126. eCollection 2021.
We aimed to explore the crucial miRNA-mRNA axis through bioinformatics analysis and provide evidences for the development of pathophysiological mechanisms and new therapies for HBV-related HCC. MiRNA (GSE76903) and mRNA (GSE77509) dataset were used to screen differentially expressed miRNAs (DE-miRNAs) and differentially expressed mRNAs (DE-mRNAs) using R software. Overlapping genes between DE-mRNAs and target genes of DE-miRNAs were identified as candidate genes. Hub genes were obtained via cytohubba analysis. The expression at protein and mRNA levels and prognostic value of hub genes were evaluated based on The Cancer Genome Atlas (TCGA) data. Key miRNA-mRNA axes were constructed according to predicted miRNA-mRNA pairs. MiRNA expression and prognostic role were respectively identified using starBase v3.0 and Kaplan-Meier plotter database. Real-time PCR was performed to verify the expression of crucial miRNAs and mRNAs. Coexpression of crucial miRNA and mRNA were analyzed using starBase v3.0. and were screened as hub genes, which were significantly upregulated at protein and mRNA levels. These up-regulated hub genes were also significantly associated with poor prognosis. Hsa-mir-195-5p/, hsa-mir-5589-3p/ and hsa-let-7c-3p/ were screened as critical miRNA-mRNA axes. Critical miRNAs were decreased in HCC, which indicates unfavourable prognosis. QPCR results showed that crucial miRNAs were decreased, whereas critical mRNAs were increased in HBV-related HCC. A reverse relationship between miRNA and mRNA in crucial axis was further verified. This study identified several miRNA-mRNA axes in HBV-related HCC. Hsa-mir-195-5p/, hsa-mir-5589-3p/ and hsa-let-7c-3p/ might serve as potential prognostic biomarkers and therapeutic targets for HBV-related HCC.
我们旨在通过生物信息学分析探讨关键的 miRNA-mRNA 轴,为乙型肝炎病毒相关 HCC 的病理生理机制和新疗法的发展提供依据。使用 R 软件筛选差异表达 miRNA (DE-miRNA) 和差异表达 mRNA (DE-mRNA),筛选来自 miRNA (GSE76903) 和 mRNA (GSE77549) 数据集的差异表达 miRNA 和差异表达 mRNA。通过 cytohubba 分析鉴定 DE-mRNA 和 DE-miRNA 靶基因之间的重叠基因作为候选基因。根据癌症基因组图谱 (TCGA) 数据评估关键基因的蛋白和 mRNA 水平的表达和预后价值。根据预测的 miRNA-mRNA 对构建关键 miRNA-mRNA 轴。使用 starBase v3.0 和 Kaplan-Meier plotter 数据库分别鉴定 miRNA 表达和预后作用。通过实时 PCR 验证关键 miRNA 和 mRNAs 的表达。使用 starBase v3.0 分析关键 miRNA 和 mRNA 的共表达。筛选出作为关键基因的 和 ,它们在蛋白和 mRNA 水平上均显著上调。这些上调的关键基因也与不良预后显著相关。筛选出关键 miRNA-mRNA 轴,包括 hsa-mir-195-5p/、hsa-mir-5589-3p/和 hsa-let-7c-3p/。在 HCC 中,关键 miRNA 减少,表明预后不良。QPCR 结果显示,HBV 相关 HCC 中关键 miRNA 减少,而关键 mRNA 增加。进一步验证了关键轴中 miRNA 和 mRNA 之间的反向关系。本研究鉴定了乙型肝炎病毒相关 HCC 中的几个 miRNA-mRNA 轴。hsa-mir-195-5p/、hsa-mir-5589-3p/和 hsa-let-7c-3p/可能作为乙型肝炎病毒相关 HCC 的潜在预后生物标志物和治疗靶点。